Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Prestige Consumer Healthcare Inc.PBH · Entity 4350 | SVP, Science and Technology | May 15, 2018 | May 17, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Prestige Consumer Healthcare Inc.
Report date May 15, 2018 · Filed May 17, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 11,081 |
Ending reported balance
After 2018-05-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2018-05-15 · Exercise / conversion · Acquired 10,879 · Balance 21,960 Row 2 · 2018-05-15 · Exercise / conversion · Acquired 9,649 · Balance 31,609 Row 3 · 2018-05-15 · Sale · Disposed 20,528 · Balance 11,081 F1: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a sale order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. This transaction was executed in multiple trades at prices ranging from $36.21 to $37.80. The price reported above reflects the weighted average sale price. |
| Employee Stock Options (rights to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.94 · Expires 2023-05-14 | Direct | 0 |
Reported balance
After 2018-05-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-05-15 · Exercise / conversion · Disposed 10,879 · Balance 0 F2: The options vested in the three installments as followed: 3,627 shares on May 14, 2014 and 3,626 shares each on May 14, 2015 and 2016. |
| Employee Stock Options (rights to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.50 · Expires 2024-05-12 | Direct | 0 |
Reported balance
After 2018-05-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-05-15 · Exercise / conversion · Disposed 9,649 · Balance 0 F3: The options vested in three installments as followed: 3,217 shares on May 12, 2015 and 3,216 shares each on May 12, 2016 and 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a sale order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. This transaction was executed in multiple trades at prices ranging from $36.21 to $37.80. The price reported above reflects the weighted average sale price.
F2: The options vested in the three installments as followed: 3,627 shares on May 14, 2014 and 3,626 shares each on May 14, 2015 and 2016.
F3: The options vested in three installments as followed: 3,217 shares on May 12, 2015 and 3,216 shares each on May 12, 2016 and 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2018 Filed May 17, 2018 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Exercise / conversionEmployee Stock Options (rights to buy) · Derivative | 9,649 | $0.00 Strike: $33.50 | $0.00 |
DisclosureSEC source: 0001144204-18-029521 · tv494468_form4.xml · derivative · entry 5 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,649 shares Expires 2024-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in three installments as followed: 3,217 shares on May 12, 2015 and 3,216 shares each on May 12, 2016 and 2017. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Exercise / conversionEmployee Stock Options (rights to buy) · Derivative | 10,879 | $0.00 Strike: $29.94 | $0.00 |
DisclosureSEC source: 0001144204-18-029521 · tv494468_form4.xml · derivative · entry 4 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,879 shares Expires 2023-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested in the three installments as followed: 3,627 shares on May 14, 2014 and 3,626 shares each on May 14, 2015 and 2016. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | SaleCommon Stock, par value $0.01 per share | 20,528 | $36.91 | $757,688.48 |
DisclosureSEC source: 0001144204-18-029521 · tv494468_form4.xml · nonDerivative · entry 3 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,081 F1 · price: The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a sale order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. This transaction was executed in multiple trades at prices ranging from $36.21 to $37.80. The price reported above reflects the weighted average sale price. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Exercise / conversionCommon Stock, par value $0.01 per share | 9,649 | $33.50 | $323,241.50 |
DisclosureSEC source: 0001144204-18-029521 · tv494468_form4.xml · nonDerivative · entry 2 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,609 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2018 Filed May 17, 2018 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Exercise / conversionCommon Stock, par value $0.01 per share | 10,879 | $29.94 | $325,717.26 |
DisclosureSEC source: 0001144204-18-029521 · tv494468_form4.xml · nonDerivative · entry 1 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2018 Filed May 14, 2018 19:07 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 1,713 | $35.82 | $61,359.66 |
DisclosureSEC source: 0001144204-18-028101 · tv494108_4.xml · nonDerivative · entry 2 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,081 Read SEC document |
| May 11, 2018 Filed May 14, 2018 19:07 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 667 | $35.82 | $23,891.94 |
DisclosureSEC source: 0001144204-18-028101 · tv494108_4.xml · nonDerivative · entry 1 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,794 Read SEC document |
| May 08, 2018 Filed May 9, 2018 20:49 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 229 | $29.10 | $6,663.90 |
DisclosureSEC source: 0001144204-18-026693 · tv493662_form4.xml · nonDerivative · entry 1 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,461 Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:01 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Exercise / conversionEmployee Stock Options (rights to buy) · Derivative | 12,876 | $0.00 Strike: $13.24 | $0.00 |
DisclosureSEC source: 0001144204-17-042324 · v472934_4.xml · derivative · entry 3 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,876 shares Expires 2022-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vested in three installments as followed: 8,839 on May 9, 2013 and 8,838 each on May 9, 2014 and 2015. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:01 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | SaleCommon Stock, par value $0.01 per share | 12,876 | $52.12 | $671,097.12 |
DisclosureSEC source: 0001144204-17-042324 · v472934_4.xml · nonDerivative · entry 2 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,690 F1 · price: This transaction was executed in multiple trades at prices ranging from $52.00 to $52.31. The price reported above reflects the weighted average sale [or purchase] price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 16:01 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Exercise / conversionCommon Stock, par value $0.01 per share | 12,876 | $13.24 | $170,478.24 |
DisclosureSEC source: 0001144204-17-042324 · v472934_4.xml · nonDerivative · entry 1 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 18, 2017 20:02 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | Tax withholdingCommon Stock, par value $0.01 per share | 849 | $52.22 | $44,334.78 |
DisclosureSEC source: 0001144204-17-028398 · v467388_form4.xml · nonDerivative · entry 1 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,690 Read SEC document |
| May 08, 2017 Filed May 16, 2017 21:50 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantEmployee Stock Option (right to buy) · Derivative | 4,512 | $0.00 Strike: $56.11 | $0.00 |
DisclosureSEC source: 0001144204-17-028007 · v467212_4.xml · derivative · entry 2 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,512 Underlying: Common Stock · 4,512 shares Expires 2027-05-08 F2 · derivative.exercise_date: The options vest in three installments as follows: 1,504 shares each on May 8, 2018, 2019 and 2020. Read SEC document |
| May 08, 2017 Filed May 16, 2017 21:50 UTC | Prestige Consumer Healthcare Inc. PBH · Entity 4350 | GrantCommon Stock, par value $0.01 per share | 1,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-028007 · v467212_4.xml · nonDerivative · entry 1 BOYKO JEAN A · CIK 0001373723 · SVP, Science and Technology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,539 F1 · shares: The restricted stock units vest in three installments as follows: 578 shares each on May 8, 2018 and 2019, 579 shares on May 8, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.